Immunology of age-related macular degeneration

J Ambati, JP Atkinson, BD Gelfand - Nature Reviews Immunology, 2013 - nature.com
Age-related macular degeneration (AMD) is a leading cause of blindness in aged
individuals. Recent advances have highlighted the essential role of immune processes in …

Inflammatory mechanisms of age-related macular degeneration

JE Knickelbein, CC Chan, HN Sen… - International …, 2015 - journals.lww.com
Late age-related macular degeneration (AMD), specifically central geographic atrophy (GA)
and choroidal neovascularization (CNV), 1 is the leading cause of irreversible vision loss in …

Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration

I Krebs, C Glittenberg, S Ansari-Shahrezaei… - British Journal of …, 2013 - bjo.bmj.com
Purpose Most of the publications on modern therapy of neovascular age-related macular
degeneration focus on the effect of the treatment. The purpose of this study is to determine …

Dexamethasone intravitreal implant as adjunctive therapy to ranibizumab in neovascular age-related macular degeneration: a multicenter randomized controlled trial

BD Kuppermann, M Goldstein, RK Maturi, A Pollack… - …, 2015 - karger.com
Purpose: To evaluate the efficacy and safety of dexamethasone intravitreal implant 0.7 mg
(DEX) as adjunctive therapy to ranibizumab in neovascular age-related macular …

Corticosteroids: triamcinolone, dexamethasone and fluocinolone

J Cáceres-del-Carpio, RD Costa, A Haider… - Retinal …, 2016 - karger.com
Steroids have been extensively used to treat macular edema due to diabetic retinopathy,
venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of …

Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide

H Kunikata, M Yasuda, N Aizawa, Y Tanaka… - American journal of …, 2013 - Elsevier
PURPOSE: To investigate the role of intravitreal injection of triamcinolone acetonide (IVTA)
in preventing photoreceptor apoptosis in eyes with rhegmatogenous retinal detachment …

Analyzing relative blood flow speeds in choroidal neovascularization using variable interscan time analysis OCT angiography

CB Rebhun, EM Moult, SB Ploner, CM Neto… - Ophthalmology …, 2018 - Elsevier
Purpose Longitudinally visualizing relative blood flow speeds within choroidal
neovascularization (CNV) may provide valuable information regarding the evolution of CNV …

Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration

D Johnson, S Sharma - Current Opinion in Ophthalmology, 2013 - journals.lww.com
Ocular and systemic safety of bevacizumab and ranibizumab in... : Current Opinion in
Ophthalmology Ocular and systemic safety of bevacizumab and ranibizumab in patients with …

Simultaneous dexamethasone intravitreal implant and anti-VEGF therapy for neovascular age-related macular degeneration resistant to anti-VEGF monotherapy

B Todorich, A Thanos, Y Yonekawa… - Journal of …, 2017 - journals.sagepub.com
Purpose: To evaluate the efficacy of a dexamethasone intravitreal implant in combination
with intravitreal anti-vascular endothelial growth factor (VEGF) agents for treatment-resistant …

Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration

A Warter, A Heinke, M Cavichini… - … Surgery, Lasers and …, 2024 - journals.healio.com
Background and Objective The purpose of this study was to analyze the safety and efficacy
of combined intravitreal anti-vascular endothelial growth factor (anti-VEGF) and steroid …